PT1883452E - Composição farmacêutica contendo um agente antiparasítico e um agente ativo escolhido entre timol, eugenol ou carvacrol - Google Patents

Composição farmacêutica contendo um agente antiparasítico e um agente ativo escolhido entre timol, eugenol ou carvacrol

Info

Publication number
PT1883452E
PT1883452E PT67559328T PT06755932T PT1883452E PT 1883452 E PT1883452 E PT 1883452E PT 67559328 T PT67559328 T PT 67559328T PT 06755932 T PT06755932 T PT 06755932T PT 1883452 E PT1883452 E PT 1883452E
Authority
PT
Portugal
Prior art keywords
carvacrol
thymol
eugenol
pharmaceutical composition
composition containing
Prior art date
Application number
PT67559328T
Other languages
English (en)
Inventor
Adnane Remmal
Original Assignee
Advanced Scient Developements
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Advanced Scient Developements filed Critical Advanced Scient Developements
Publication of PT1883452E publication Critical patent/PT1883452E/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A61K31/05—Phenols
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/10—Anthelmintics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Virology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
PT67559328T 2005-05-13 2006-05-15 Composição farmacêutica contendo um agente antiparasítico e um agente ativo escolhido entre timol, eugenol ou carvacrol PT1883452E (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/IB2005/001314 WO2006120495A1 (fr) 2005-05-13 2005-05-13 Composition pharmaceutique comprenant un antiviral, an antitumoral ou un antiparasitaire, et un actif choisi parmi le carveol, le thymol, l’eugenol, le borneol et le carvacrol

Publications (1)

Publication Number Publication Date
PT1883452E true PT1883452E (pt) 2013-02-18

Family

ID=35427309

Family Applications (2)

Application Number Title Priority Date Filing Date
PT67559328T PT1883452E (pt) 2005-05-13 2006-05-15 Composição farmacêutica contendo um agente antiparasítico e um agente ativo escolhido entre timol, eugenol ou carvacrol
PT06744739T PT1879656E (pt) 2005-05-13 2006-05-15 Composição farmacêutica compreendendo um agente antitumoral e um agente activo escolhido entre carveol, timol e carvacrol

Family Applications After (1)

Application Number Title Priority Date Filing Date
PT06744739T PT1879656E (pt) 2005-05-13 2006-05-15 Composição farmacêutica compreendendo um agente antitumoral e um agente activo escolhido entre carveol, timol e carvacrol

Country Status (16)

Country Link
US (2) US20080171768A1 (pt)
EP (2) EP1883452B1 (pt)
JP (1) JP5073651B2 (pt)
CN (2) CN101175532B (pt)
AP (1) AP2437A (pt)
AT (1) ATE554827T1 (pt)
BR (2) BRPI0610123A2 (pt)
CA (2) CA2606887C (pt)
DK (2) DK1879656T3 (pt)
EA (1) EA015168B1 (pt)
ES (2) ES2386292T3 (pt)
MA (2) MA29908B1 (pt)
PT (2) PT1883452E (pt)
TN (2) TNSN07423A1 (pt)
WO (3) WO2006120495A1 (pt)
ZA (1) ZA200710785B (pt)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2008029136A1 (en) * 2006-09-05 2008-03-13 Ultra Biotech Limited Pharmaceutical composition and method for cancer treatment based on combinational use of conventional or plant-derived anticancer agents and geranium oil or compounds thereof
US20080293648A1 (en) * 2007-01-05 2008-11-27 Saha Pharmaceuticals, Inc. Compositions and Methods for Cancer Treatment
EP2408771B1 (en) 2009-03-17 2016-11-16 Concert Pharmaceuticals, Inc. Pyrazinoisoquinoline compounds
US9132103B2 (en) 2009-09-24 2015-09-15 Conopco, Inc. Disinfecting agent comprising eugenol, terpineol and thymol
CN103354741B (zh) 2010-12-07 2016-01-13 荷兰联合利华有限公司 口腔护理组合物
CN103998011B (zh) 2011-11-03 2016-11-23 荷兰联合利华有限公司 个人清洁组合物
CN102579449B (zh) * 2012-03-30 2013-08-07 厦门大学 一种可提高肿瘤对紫杉醇敏感性的联合用药
GB201404505D0 (en) * 2013-09-06 2014-04-30 Mars Inc Oral anti-parasitic composition
WO2016037131A1 (en) 2014-09-05 2016-03-10 Symbiomix Therapeutics, Llc Secnidazole for use in the treatment of bacterial vaginosis
EP3270907A1 (en) * 2015-03-20 2018-01-24 Sammy Oyoo OPIYO Use of suramin and arginase inhibitors in malignant neoplasia
US11253501B2 (en) 2015-06-01 2022-02-22 Lupin Inc. Secnidazole formulations and use in treating bacterial vaginosis
CN105147647A (zh) * 2015-08-19 2015-12-16 华南理工大学 右旋龙脑作为抗肿瘤药物增敏剂的应用
EP3463479A2 (fr) 2016-06-02 2019-04-10 Advanced Scientific Developements Formulation pharmaceutique de cinéol et d'amoxicilline
MX2019011678A (es) * 2017-03-28 2020-02-12 IRP Health Pty Ltd Alcaloides de berberina en la prevencion y/o tratamiento de una enfermedad intestinal.
CN112972437B (zh) * 2021-02-19 2022-03-25 沈阳伟嘉生物技术有限公司 一种包含碘硝酚的长效外用制剂及其制备方法和用途

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3634697A1 (de) * 1986-10-11 1988-04-21 Dentaire Ivoclar Ets Dentalwerkstoff zur bekaempfung von karies und parodontose
DE19509697A1 (de) * 1995-03-08 1996-09-12 Schering Ag Neue Borneole, Verfahren zu ihrer Herstellung und ihre pharmazeutische Verwendung
JPH11507356A (ja) * 1995-06-07 1999-06-29 アブマックス，インコーポレイティド 経口薬理化合物の生物有用性を高めるためのエッセンシャルオイルの利用
JP2002531512A (ja) * 1998-12-07 2002-09-24 エコスマート テクノロジーズ，インコーポレーテッド 天然植物精油を用いた癌治療薬配合物および方法
US6536268B1 (en) * 1999-11-01 2003-03-25 Siemens Vdo Automotive Corporation Utilizing increasing width for identification voltages
DE10007771A1 (de) * 2000-02-14 2001-08-23 Kleine & Steube Entoxin Gmbh Immunmodulatorisch wirksame Zusammensetzungen, Verfahren zu ihrer Herstellung und ihre Verwendung
JP2004513153A (ja) * 2000-11-09 2004-04-30 イェルク・ペーター・シューア Ｇｒａｓ香料またはその誘導体を含む殺菌性組成物を含有する薬物
WO2002053138A2 (en) * 2001-01-02 2002-07-11 Elisabeth Shanahan-Prendergast Treatment for inhibiting neoplastic lesions using incensole and/or furanogermacrens
US20030064948A1 (en) * 2001-02-08 2003-04-03 Alfred Fahr Invasomes for therapy of disorders, their preparation and use
WO2003069993A1 (en) * 2002-02-20 2003-08-28 Pharmessen Scientific, Inc. Antimicrobial therapeutic compositions and methods of use
US20030225003A1 (en) * 2002-04-18 2003-12-04 Dusan Ninkov Antimicrobial therapeutic compositions for oral and topical use
WO2004052308A2 (en) * 2002-12-10 2004-06-24 Biosynexus Incorporated Topical anti-infective formulations
US20040151771A1 (en) * 2003-02-04 2004-08-05 Gin Jerry B. Long-lasting, flavored dosage forms for sustained release of beneficial agents within the mouth
CN100343223C (zh) * 2005-03-07 2007-10-17 常州市智能动物药业有限公司 百里酚或香芹酚的酯类化合物、制备方法及其药物活性组合物

Also Published As

Publication number Publication date
DK1879656T3 (da) 2012-07-23
BRPI0610130A2 (pt) 2012-09-25
MA29573B1 (fr) 2008-06-02
JP5073651B2 (ja) 2012-11-14
WO2006120564A1 (fr) 2006-11-16
TNSN07423A1 (fr) 2009-03-17
JP2008540505A (ja) 2008-11-20
TNSN07426A1 (fr) 2009-03-17
CA2606887A1 (fr) 2006-11-16
BRPI0610123A2 (pt) 2012-09-25
ES2386292T3 (es) 2012-08-16
ES2399348T3 (es) 2013-03-27
WO2006120495A1 (fr) 2006-11-16
CN101193682A (zh) 2008-06-04
CA2608061A1 (fr) 2006-11-16
AP2437A (en) 2012-08-31
ZA200710785B (en) 2009-06-24
EP1883452B1 (fr) 2012-12-19
MA29908B1 (fr) 2008-11-03
CN101193682B (zh) 2012-06-13
WO2006120568A2 (fr) 2006-11-16
US20080171768A1 (en) 2008-07-17
EA200702486A1 (ru) 2008-06-30
PT1879656E (pt) 2012-07-25
DK1883452T3 (da) 2013-02-25
EP1879656A1 (fr) 2008-01-23
CN101175532B (zh) 2011-12-28
WO2006120568A3 (fr) 2007-08-23
ATE554827T1 (de) 2012-05-15
US20080171709A1 (en) 2008-07-17
CA2608061C (fr) 2014-07-15
EP1879656B1 (fr) 2012-04-25
AP2007004228A0 (en) 2007-12-31
EA015168B1 (ru) 2011-06-30
CA2606887C (fr) 2014-07-15
EP1883452A2 (fr) 2008-02-06
CN101175532A (zh) 2008-05-07

Similar Documents

Publication Publication Date Title
PT1883452E (pt) Composição farmacêutica contendo um agente antiparasítico e um agente ativo escolhido entre timol, eugenol ou carvacrol
PT1879655E (pt) Composição farmacêutica compreendendo um agente antibacteriano e uma substância activa seleccionada a partir de carveol, carvacrol, alfa-ionona, beta-ionona, e timol
AP2405A (en) Cannabinoid active pharmaceutical ingredient for improved dosage forms.
WO2006135854A3 (en) Antiseptic compositions
AP2441A (en) Low-faoming aqueous formulations used for crop protection
IL228402A0 (en) Nitro-cyclic compounds, their pharmaceutical preparations and their uses
ZA200807767B (en) Nitrogenated heterocyclic derivative, and pharmaceutical agent comprising the derivative as active ingredient
IL199397A (en) Hetero-ring compounds, pharmaceuticals containing them, and their medicinal products
IL193274A0 (en) Pharmaceutical formulation for aerosols, comprising two or more active agents and at least one surfactant
SI1863812T1 (sl) Spojine za inhibicijo dipeptidil peptidaze IV postopek priprave le te in le to kot učinkovino vsebujoč farmacevtski sestavek
WO2007100776A3 (en) Antimicrobial compositions and methods for locking catheters
WO2005091853A3 (en) Methods and compositions for treating il-13 related pathologies
IL185277A0 (en) Pharmaceutical compositions containing roflumilast for the treatment of diabetes
EP2078731A4 (en) PHARMACEUTICAL COMPOSITION COMPRISING ANTI-HB-EGF ANTIBODY AS ACTIVE INGREDIENT
WO2007127333A3 (en) Compositions for the treatment and prevention of eyelid swelling
DK1879654T3 (da) Farmaceutisk kombination af et afsvampningsmiddel og en aktiv substans, som navnlig er eugenol og carvacrol
WO2009061431A3 (en) Compositions for the treatment and prevention of eyelid swelling comprising an osmotically active ingredient and a vasoconstrictor
BRPI0814891A2 (pt) Composição farmacêutica contendo composto oticamente ativo tendo atividade agonista de receptor de trombopoietina, e intermediário do mesmo.
EP2015740A4 (en) NEW LOW-DOSED PHARMACEUTICAL COMPOSITIONS WITH NIMESULID, PREPARATION AND USE
EP1893204A4 (en) FORMULATIONS CONTAINING FLUPHENAZINE OR ITS DERIVATIVES
EP1819323A4 (en) PHARMACEUTICAL COMPOSITION WITH ANTI-SKIN COMPOSER
WO2007009606A3 (de) Desinfektionsmittel enthaltend eine kombination biozider und ein keratolytikum
IL185197A0 (en) Ophthalmological pharmaceutical compositions
BRPI0821373A2 (pt) Composições farmacêuticas contendo ao menos um princípio ativo protéico protegido de enzimas digestivas
IL192206A0 (en) Topical mecamylamine formulations for ocular administration and uses thereof